Unilever (NYSE: UL) and DS Healthcare Group (OTCMKTS:DSKX) are both non-cyclical consumer goods & services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability.
This table compares Unilever and DS Healthcare Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|DS Healthcare Group||-62.31%||-1,304.25%||-117.85%|
6.8% of Unilever shares are held by institutional investors. Comparatively, 0.0% of DS Healthcare Group shares are held by institutional investors. 1.0% of Unilever shares are held by insiders. Comparatively, 19.4% of DS Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Risk and Volatility
Unilever has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 8.77, suggesting that its share price is 777% more volatile than the S&P 500.
Unilever pays an annual dividend of $1.76 per share and has a dividend yield of 3.4%. DS Healthcare Group does not pay a dividend. Unilever pays out 65.9% of its earnings in the form of a dividend. DS Healthcare Group has increased its dividend for 2 consecutive years.
Earnings and Valuation
This table compares Unilever and DS Healthcare Group’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Unilever||$60.71 billion||1.06||$6.84 billion||$2.67||19.62|
|DS Healthcare Group||$12.95 million||0.02||-$6.93 million||($0.28)||-0.04|
Unilever has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Unilever, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings for Unilever and DS Healthcare Group, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|DS Healthcare Group||0||0||0||0||N/A|
Unilever currently has a consensus target price of $26.00, indicating a potential downside of 50.37%. Given Unilever’s higher possible upside, research analysts plainly believe Unilever is more favorable than DS Healthcare Group.
Unilever beats DS Healthcare Group on 12 of the 16 factors compared between the two stocks.
Unilever Company Profile
Unilever PLC is a fast-moving consumer goods (FMCG) company. The Company’s segments include Personal Care, which primarily includes sales of skin care and hair care products, deodorants and oral care products; Foods, which primarily includes sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads; Home Care, which primarily includes sales of home care products, such as powders, liquids and capsules, soap bars and a range of cleaning products, and Refreshment, which primarily includes sales of ice cream and tea-based beverages. The Company’s geographical segments include Asia/AMET/RUB, The Americas and Europe. Its brands include Axe, Dirt is Good (Omo), Dove, Family Goodness (Rama), Heartbrand (Wall’s), Hellmann’s, Knorr, Lipton, Lux, Magnum, Rexona, Sunsilk and Surf. The Company operates in more than 100 countries, selling its products in more than 190 countries. The Company operates approximately 310 factories in over 70 countries.
DS Healthcare Group Company Profile
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
Receive News & Ratings for Unilever Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unilever and related companies with MarketBeat.com's FREE daily email newsletter.